The Effect of Dyadic Self-Care Education Provided to Breast Cancer Patient-Caregiver Dyads on Patient and Caregiver Outcomes
Starting soon · Not applicable
Conditions studied: Breast Cancer, Caregiver, Caregiver Anxiety, Self Care, Dyadic Intervention, Education, Caregiver Burden
In brief
This randomized controlled trial aims to evaluate the effect of dyadic self-care education provided to breast cancer patient-caregiver dyads receiving outpatient chemotherapy on patient self-care behaviors, anxiety levels, and caregiver anxiety levels and caregiver burden. Participants will be randomly assigned to either a dyadic self-care education intervention or routine care. Outcomes will be assessed at baseline and follow-up using validated instruments.
Key facts
- Study ID
- NCT07742969
- Run by
- Ulviye Aydan NACAK
- People needed
- 156
- Starts
- 2026-08-15
- Expected to finish
- 2026-10-15
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients:
- Female patients aged 18 years or older.
- Diagnosed with stage II or III breast cancer.
- Aware of their breast cancer diagnosis.
- Receiving outpatient chemotherapy after mastectomy.
- Having received at least one cycle of an EC (epirubicin-cyclophosphamide) or AC (doxorubicin-cyclophosphamide) chemotherapy regimen.
- Able to read and write Turkish.
- Having a primary caregiver who is willing to participate in the study.
- Living with the primary caregiver.
- Conscious, able to communicate effectively, and able to provide informed consent.
- No diagnosed psychiatric disorder.
- Primary Caregivers:
- Aged 18 years or older.
- Able to read and write Turkish.
- Living with the patient.
- Being the patient's spouse, parent, child, friend, or another relative.
- Assuming the main responsibility for the patient's care.
- Willing and able to cooperate and provide informed consent.
- No diagnosed psychiatric disorder.
You may not qualify if…
- Patients:
- Having experienced a major adverse life event within the previous 3 months, such as bereavement or divorce.
- Admission to an intensive care unit during the study.
- Progression of the disease to stage IV breast cancer.
- Death or loss to follow-up.
- Primary Caregivers:
- Having experienced a major adverse life event within the previous 3 months, such as bereavement or divorce.
- Deterioration in health that prevents continued participation.
- Transfer of the primary caregiving responsibility to another person.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.